Anne C. Heatherington

Author

Also Known As

A C Heatherington, A Heatherington, A. C. Heatherington, A.C. Heatherington, Anne C Heatherington, Anne C. Heatherington, Anne Heatherington

Publications

980

Citations

H-Index

Concepts

All Affiliations

Amgen (United States)University of Manchester Pfizer (United States)The University of Melbourne Pfizer (United Kingdom)

About

Anne C. Heatherington is an author at Amgen (United States) specializing in pharmacology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	11	458
2	Education	2	2	51
3	Health Sciences	2	2	53
4	Language Studies	1	1	13
5	Social Sciences	1	1	38

Anne C. Heatherington

Publications

877

Citations

H-Index

Page 1

	Year	Citations
Passage of erythropoietic agents across the blood–brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfa William A. Banks, Nelson L. ‘Shasha’ Jumbe, Catherine L. Farrell, European Journal of Pharmacology Blood–brain BarrierAnalog Darbepoetin AlfaHematologyPharmacologyBlood Cell	2004	143
Pharmacokinetics of novel erythropoiesis stimulating protein (NESP) in cancer patients: preliminary report Anne C. Heatherington, J. Schüller, AJ Mercer British Journal of Cancer	2001	76
Pharmacokinetics of darbepoetin alfa in pediatric patients with chronic kidney disease Gary Lerner, Arundhati S. Kale, Bradley A. Warady, Pediatric Nephrology Darbepoetin AlfaRenal FunctionMedicineKidney FailurePharmacology	2002	72
Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysis* Michael Allon, Ken Kleinman, Michael H. Walczyk, Clinical Pharmacology & Therapeutics	2002	70
Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to Sheep Danielle N McLennan, Christopher J. H. Porter, Glenn A. Edwards, Journal of Pharmacology and Experimental Therapeutics	2005	54
Development and evaluation of a population pharmacokinetic-pharmacodynamic model of darbepoetin alfa in patients with nonmyeloid malignancies undergoing multicycle chemotherapy Balaji Agoram, Anne C. Heatherington, Marc R. Gastonguay The AAPS Journal Darbepoetin AlfaOncologyPharmacokinetic ModelingMulticycle ChemotherapyPharmacology	2006	52
A Multiscale Model of Interleukin‐6–Mediated Immune Regulation in Crohn's Disease and Its Application in Drug Discovery and Development Gaurav Dwivedi, LJ Fitz, Martin Hegen, CPT Pharmacometrics & Systems Pharmacology	2014	41
A Pharmacokinetic/Pharmacodynamic Comparison of SAAM II and PC/WinNonlin Modeling Software Anne C. Heatherington, Paolo Vicini, Hellmut Golde Journal of Pharmaceutical Sciences	1998	40
Discovery of a Selective Small-Molecule Melanocortin-4 Receptor Agonist with Efficacy in a Pilot Study of Sexual Dysfunction in Humans Mark I. Lansdell, David Hepworth, Andrew Calabrese, Journal of Medicinal Chemistry Sexual HealthUrologyErectile DysfunctionFunctional SelectivityMedicine	2010	38
The Absorption of Darbepoetin Alfa Occurs Predominantly via the Lymphatics Following Subcutaneous Administration to Sheep Danielle N McLennan, Christopher J. H. Porter, Glenn A. Edwards, Pharmaceutical Research Animal PhysiologyCaprineAllergyAnimal ScienceMedicine	2006	38

Page 1